Ritu Baral Says Biotech Lives Or Dies By Transparency Of Regulatory Authorities

Ritu Baral talks the future of the biotech industry, noting that the space as a whole can live or die by the transparency of regulatory authorities. She also mentions that investors are currently concerned over FDA conservatism, and there could be a potential gene-editing bubble.

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US

Ritu Baral Says Biotech Lives Or Dies By Transparency Of Regulatory Authorities

Ritu Baral talks the future of the biotech industry, noting that the space as a whole can live or die by the transparency of regulatory authorities. She also mentions that investors are currently concerned over FDA conservatism, and there could be a potential gene-editing bubble.

ON AIR
7:00 am
Market Overtime
replay

Get Market Minute

Daily insights for every investor

FOLLOW US